MARÍA DOLORES
GUTIÉRREZ LÓPEZ
Profesora titular de universidad
Argitalpenak (46) MARÍA DOLORES GUTIÉRREZ LÓPEZ argitalpenak
2022
-
Influx of kynurenine into the brain is involved in the reduction of ethanol consumption induced by Ro 61-8048 after chronic intermittent ethanol in mice
British Journal of Pharmacology, Vol. 179, Núm. 14, pp. 3711-3726
2021
-
Addiction and the kynurenine pathway: A new dancing couple?
Pharmacology and Therapeutics, Vol. 223
-
Increased kynurenine concentration attenuates serotonergic neurotoxicity induced by 3,4-methylenedioxymethamphetamine (MDMA) in rats through activation of aryl hydrocarbon receptor
Neuropharmacology, Vol. 187
2019
-
Changes in brain kynurenine levels via gut microbiota and gut-barrier disruption induced by chronic ethanol exposure in mice
FASEB journal : official publication of the Federation of American Societies for Experimental Biology, Vol. 33, Núm. 11, pp. 12900-12914
2018
-
Increasing kynurenine brain levels reduces ethanol consumption in mice by inhibiting dopamine release in nucleus accumbens
Neuropharmacology, Vol. 135, pp. 581-591
2017
-
3,4-Methylenedioxymethamphetamine (MDMA, ecstasy) produces edema due to BBB disruption induced by MMP-9 activation in rat hippocampus
Neuropharmacology, Vol. 118, pp. 157-166
-
Disruption of blood–brain barrier integrity in postmortem alcoholic brain: preclinical evidence of TLR4 involvement from a binge-like drinking model
Addiction Biology, Vol. 22, Núm. 4, pp. 1103-1116
2014
-
3,4-Methylenedioxymethamphetamine (MDMA, ecstasy) disrupts blood-brain barrier integrity through a mechanism involving P2X7 receptors
International Journal of Neuropsychopharmacology, Vol. 17, Núm. 8, pp. 1243-1255
-
The JNK inhibitor, SP600125, potentiates the glial response and cell death induced by methamphetamine in the mouse striatum
International Journal of Neuropsychopharmacology, Vol. 17, Núm. 2, pp. 235-246
2013
-
A study on the effect of JNK inhibitor, SP600125, on the disruption of blood-brain barrier induced by methamphetamine
Neurobiology of Disease, Vol. 50, Núm. 1, pp. 49-58
-
ALCAM/CD166 adhesive function is regulated by the tetraspanin CD9
Cellular and Molecular Life Sciences, Vol. 70, Núm. 3, pp. 475-493
-
Cocaine potentiates MDMA-induced oxidative stress but not dopaminergic neurotoxicity in mice: Implications for the pathogenesis of free radical-induced neurodegenerative disorders
Psychopharmacology, Vol. 230, Núm. 1, pp. 125-135
-
Implicación de la molécula de adhesión ALCAM en el daño cerebral. Modelo de daño neuronal mediante la administración de MDMA/éxtasis en rata
Trauma (Spain), Vol. 24, Núm. 2, pp. 101-108
2012
-
Velázquez. Manual de farmacología básica y clínica
lan.
Editorial Médica Panamericana
2011
-
Changes in interleukin-1 signal modulators induced by 3,4-methylenedioxymethamphetamine (MDMA): Regulation by CB2 receptors and implications for neurotoxicity
Journal of Neuroinflammation, Vol. 8
-
Functional interplay between tetraspanins and proteases
Cellular and Molecular Life Sciences, Vol. 68, Núm. 20, pp. 3323-3335
-
Increased interleukin-1β levels following low dose MDMA induces tolerance against the 5-HT neurotoxicity produced by challenge MDMA
Journal of Neuroinflammation, Vol. 8
-
The sheddase activity of ADAM17/TACE is regulated by the tetraspanin CD9
Cellular and Molecular Life Sciences, Vol. 68, Núm. 19, pp. 3275-3292
2010
-
Administration of neurotoxic doses of MDMA reduces sensitivity to ethanol and increases GAT-1 immunoreactivity in mice striatum
Psychopharmacology, Vol. 207, Núm. 4, pp. 671-679
-
Desarrollo de un Modelo Estadístico Universal para Proteómica Cuantitativa mdiante Marcaje IsotÓpico Estable
Proteómica: revista de la Sociedad Española de Proteómica, Núm. 5, pp. 101-103